Exelixis Inc. Common Stock vs Truist Financial Corporation Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Truist Financial Corporation Common Stock trades at $46.2 (market cap $56.41B). The key difference: Truist Financial Corporation Common Stock is far larger — about 3.9× Exelixis Inc. Common Stock's market cap, and Truist Financial Corporation Common Stock pays a 4.5% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Truist Financial Corporation Common Stock for 0 Days on average.
| EXEL | TFC | |
|---|---|---|
Market Cap | $14.62B | $56.41B |
Volume | 2,684,957 | 9,045,741 |
Sector | Health | Financials |
52-Week High | $59.13 | $55.81 |
52-Week Low | $34.54 | $41.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $122.69B |
Dividend Yield | — | 4.5% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Truist Financial provides consumer and commercial banking, wealth management, insurance, and investment services in the United States.
Read more on TFC →